EUVIMEDEUVIMED entdecken
KohortenstudieOpen Access · CC BY 4.0

Treatment Timing and Early Hair Regrowth in Relation to Response to Intravenous Methylprednisolone Pulse Therapy in Alopecia Areata: A Retrospective Cohort Study

Mayu Ishizaki iD, Takeshi Araki iD, Marie Miyagawa, Yukie Endo iD, Masahito Yasuda iD, Sei-Ichiro Motegi iD

The Journal of Dermatology · 13.11.2026

DOI: 10.1111/1346-8138.70575 ↗

Kurz gefasst

Kohortenstudie in der Zeitschrift The Journal of Dermatology, online erschienen am 13.11.2026. Verfasst von Mayu Ishizaki und 5 weiteren Autor:innen. Beteiligte Einrichtung: Department of Dermatology, Gunma University Graduate School of Medicine, Maebashi, Japan. Die Arbeit nennt 11 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

We retrospectively analyzed 72 intravenous methylprednisolone (IVMP)‐treated patients with moderate to severe alopecia areata to assess predictors of ≥ 50% improvement in the Severity of Alopecia Tool score at 6 months, the predictive value of 3‐month hair regrowth and exploratory long‐term outcomes. At 6 months, 39 patients (54.2%) responded. Shorter disease duration was associated with response (OR: per 1‐unit increase in ln(months): 0.69, 95% CI: 0.51–0.95; p = 0.021), as was treatment within 6 months (OR: 4.89, 95% CI: 1.76–13.63; p = 0.002). After excluding possible self‐healing acute diffuse and total alopecia cases, the adjusted association between disease duration and 6‐month treatment response was no longer significant (OR: 0.74, 95% CI: 0.54–1.02; p = 0.063), whereas treatment initiation within 6 months of disease onset remained significantly associated with response. Among 46 patients with 3‐month data, hair regrowth predicted the 6‐month response (AUC: 0.872); a 20% threshold yielded 100% specificity and 70.8% sensitivity. Exploratory long‐term outcomes were more favorable with shorter disease duration. Three‐month hair regrowth may provide an early quantitative indicator of IVMP response, while the independent continuous association between disease duration and outcome warrants further investigation.

Schlagwörter

Stichwörter der Autor:innen

alopecia areatacorticosteroiddisease durationintravenous methylprednisolone pulse therapytreatment response

Autor:innen und Institutionen

  • Department of Dermatology, Gunma University Graduate School of Medicine, Maebashi, Japan.
  • Miyagawa Dermatology Clinic, Takasaki, Japan.

ORCID-Profile: Mayu Ishizaki, Takeshi Araki, Yukie Endo, Masahito Yasuda, Sei-Ichiro Motegi

Zitieren

APA

Ishizaki, M., Araki, T., Miyagawa, M., Endo, Y., Yasuda, M., & Motegi, S. I. (2026). Treatment Timing and Early Hair Regrowth in Relation to Response to Intravenous Methylprednisolone Pulse Therapy in Alopecia Areata: A Retrospective Cohort Study. The Journal of Dermatology. https://doi.org/10.1111/1346-8138.70575

Vancouver

Ishizaki M, Araki T, Miyagawa M, Endo Y, Yasuda M, Motegi SI. Treatment Timing and Early Hair Regrowth in Relation to Response to Intravenous Methylprednisolone Pulse Therapy in Alopecia Areata: A Retrospective Cohort Study. The Journal of Dermatology. 2026. doi:10.1111/1346-8138.70575

BibTeX
@article{Ishizaki2026,
  author = {Ishizaki, Mayu and Araki, Takeshi and Miyagawa, Marie and Endo, Yukie and Yasuda, Masahito and Motegi, Sei-Ichiro},
  title = {Treatment Timing and Early Hair Regrowth in Relation to Response to Intravenous Methylprednisolone Pulse Therapy in Alopecia Areata: A Retrospective Cohort Study},
  journal = {The Journal of Dermatology},
  year = {2026},
  doi = {10.1111/1346-8138.70575}
}
Kostenlos starten →